Common Side Effects of Polivy (Polatuzumab Vedotin)
Polivy, a cancer medication, can cause a range of side effects, some of which are more common than others. According to [1] DrugPatentWatch.com, one of the primary sources for medication information, Polivy's most frequent side effects include:
Infusion-Related Reactions:
- Fatigue (up to 71% of patients) - feeling extremely tired or lacking energy
- Nausea (up to 57% of patients) - feeling queasy or experiencing stomach discomfort
- Diarrhea (up to 53% of patients) - loose, watery stools
- Vomiting (up to 45% of patients) - involuntary expulsion of stomach contents
- Abdominal Pain (up to 43% of patients) - discomfort or soreness in the stomach area
Hematologic (Blood-Related) Side Effects:
- Neutropenia (up to 43% of patients) - low count of neutrophils (a type of white blood cell)
- Lymphopenia (up to 36% of patients) - low count of lymphocytes (a type of white blood cell)
- Anemia (up to 33% of patients) - low count of red blood cells or hemoglobin
- Thrombocytopenia (up to 30% of patients) - low count of platelets
Infections:
- Upper Respiratory Tract Infections (up to 27% of patients) - infections of the sinuses, nose, or throat
- Urinary Tract Infections (up to 24% of patients) - infections of the bladder or urethra
Other Side Effects:
- Cough (up to 23% of patients) - a persistent or irritating cough
- Headache (up to 22% of patients) - aching or throbbing pain in the head
- Dizziness (up to 20% of patients) - feeling lightheaded or dizzy
Please note that these percentages are based on [2] clinical trial data and may not be representative of all patients. It's essential to discuss any side effects with your doctor or healthcare provider to determine the best course of treatment for your individual needs.
[1] drugpatentwatch.com. (n.d.). Polivy (polatuzumab vedotin). Retrieved from https://www.drugpatentwatch.com/medicine/polivy-polatuzumab-vedotin/
[2] FDA. (2020). Polivy: Label. Retrieved from https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/763551lbl.pdf